Fred's, Inc. (FRED)
(Delayed Data from NSDQ)
$1.38 USD
+0.07 (5.34%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.39 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.38 USD
+0.07 (5.34%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.39 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Fred's Confirms Sale of Specialty Pharmacy Unit, Stock Up
by Zacks Equity Research
Fred's (FRED) implements its long-standing plans to divest specialty pharmacy segment to CVS Health Corporation.
Fred's (FRED) Q4 Loss Widens Year Over Year, Stock Loses 6%
by Zacks Equity Research
Fred's (FRED) continues to struggle with its front store business. However, the company remains focused on turnaround.
Fred's Stock Jumps Over 13% in a Day, 2 Things You Must Note
by Zacks Equity Research
Fred's (FRED) has rescheduled its earnings announcement date.This is solely connected to Fred's plans to divest its specialty pharmacy business.
Factors Setting the Stage for Fred's (FRED) in Q4 Earnings
by Zacks Equity Research
Fred's (FRED) has been reeling under soft comparable store sales for quite some time now. Let's see if Fred???s strategic initiatives can provide any respite in Q4.
Can Strategic Efforts Aid Fred's to Achieve a Turnaround?
by Zacks Equity Research
Fred's (FRED) focuses on pharmacy organization and expense reduction to achieve turnaround. However, receding comps continue to hurt.
Fred's (FRED) Sluggish Store Sales Keep Investors at Bay
by Zacks Equity Research
Fred's (FRED) continues to witness dismal comps and store closures. Also, cancelled dividend and merger deal make this retailer a less-favored pick.
Fred's Tanks 79% in a Year: Any Chances of Revival Ahead?
by Zacks Equity Research
Fred's (FRED) has been struggling with its dismal comps performance stemming from receding traffic and store closures. Also, management cancelled its quarterly dividend recently.
SolarEdge, Fred's, DXC Technology, Anglo American and Western Digital as Zacks Bull and Bear of the Day
by Zacks Equity Research
SolarEdge, Fred's, DXC Technology, Anglo American and Western Digital as Zacks Bull and Bear of the Day
Bear of the Day: Fred's (FRED)
by David Bartosiak
The unique combo of value-focused retailer with a drug store is giving up ground to the competition
Fred's (FRED) Shares Plunge on Q3 Loss, Dividend Cancelled
by Zacks Equity Research
Fred's (FRED) third-quarter fiscal 2017 results hurt by store closures and lower comps. Further, the company announced cancellation of cash dividends.
Declining Comps Likely to Hurt Fred's (FRED) in Q3 Earnings
by Zacks Equity Research
Fred's (FRED) third-quarter fiscal 2017 performance is expected to be hurt by dismal comps trend.
Why Is Fred's (FRED) Down 12.6% Since the Last Earnings Report?
by Zacks Equity Research
Fred's (FRED) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Can Fred's Strategies Help It Counter Slow Comps & Traffic?
by Zacks Equity Research
Fred's (FRED) has been struggling with declining store traffic and sluggish comps over the past few quarters. The company has been focusing on cost reduction and internal restructuring.
Fred's (FRED) Q2 Loss Narrower Than Expected, Shares Surge
by Zacks Equity Research
Fred's (FRED) reported narrower-than-expected loss in second-quarter fiscal 2017, with sales meeting the Zacks Consensus Estimate. Also, its comps showed improvement despite a tough retail landscape.
Fred's, Inc. (FRED) Soars: Stock Adds 17% in Session
by Zacks Equity Research
Fred's, Inc. (FRED) was a big mover last session, as the company saw its shares rise over 17% on the day after the company reported a narrower-than-expected loss in its second-quarter earnings announcement.
Fred's Pharmacy (FRED) Skyrockets After Q2 Earnings Report
by Ryan McQueeney
Shares of Fred's Pharmacy (FRED) were up more than 12.5% through morning trading hours Wednesday.
Will Declining Comps Hurt Fred's (FRED) This Earnings Season?
by Zacks Equity Research
Fred's (FRED) has been posting dismal comps for quite some time now owing to the sale of low productive discontinued inventory. Let's see if the trend continues.
What You Should Know About Fred's Apart From Dismal Comps
by Zacks Equity Research
Fred's (FRED) is yet to recover from the cancelled Walgreens-Rite Aid merger. The company has also been struggling with declining sales owing to lower comps and store closures.
Implied Volatility Surging for Fred's, Inc. (FRED) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Fred's, Inc. (FRED) stock based on the movements in the options market lately.
Retail Industry Stock Outlook - July 2017
by Zacks Equity Research
To put it simply, the retail sector is on transformation mode ??? with store-based retailers now ditching their traditional stores and embracing omni-channel concepts.
Fred's Posts Dismal Comparable June Store Sales, Stock Down
by Zacks Equity Research
Fred's, (FRED), which has been struggling to recover from the blow of a failed merger between Rite Aid Corporation (RAD) and Walgreens Boots Alliance (WBA), recently announced soft June comparable store sales.
Should You Get Rid of Fred's, Inc. (FRED) Now?
by Zacks Equity Research
One stock that you may want to consider dropping is Fred's, Inc. (FRED), which has witnessed a significant price decline in the past four weeks
Rite Aid (RAD) Tanks on Merger Fallout: New Deal Bodes Well?
by Zacks Equity Research
Rite Aid (RAD) saw its shares plummet as its long-awaited acquisition by Walgreens was terminated.
Fred's Stock Falls, Walgreens & Rite Aid Merger Deal Revised
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy lost over 20% yesterday after Walgreens Boots Alliance, Inc. (WBA) decided not to proceed with its planned takeover of the rival drugstore Rite Aid Corporation (RAD) due to various antitrust issues, as per Bloomberg. The cancelled merger significantly hurt Rite Aid???s stock too, which fell 26.46% yesterday.
Walgreens, Rite Aid Ditch Long-Suffering Drugstore Merger
by Madeleine Johnson
On Thursday, Walgreens Boots Alliance (WBA) announced that it has abandoned efforts to merge with fellow drugstore chain Rite Aid (RAD). Instead, Walgreens will purchase almost half if its rivals stores in a new deal.